FENNELL GEORGE

IDXX EVP Fennell George sells 11,345 shares for $7.3M across 8 transactions, reducing holdings by -53.6%.

George executed 8 separate sales on 2026-02-10 totaling 11,345 shares (11.3K shares) for $7,336,993.27 ($7.3M) at an average price of $646.72, reducing his holdings from 21,168 shares to 9,823 shares (a -53.6% reduction). This substantial liquidation comes as IDXX trades 15.4% below its 52-week high, with the stock down 10.5% over the prior 30 days and 7.5% over 90 days. Reviewing his same-ticker history at IDXX, George's prior 5 sales showed a 80% well-timed rate at the 90-day mark (4 of 5 preceded subsequent declines), with the most recent sale on 2025-02-10 followed by -10.8% over 30 days. His cross-ticker track record documents a 83.33% well-timed rate on 6 prior sells with average 90-day returns of -11.6%, suggesting a pattern of selling ahead of downward moves. The magnitude of this reduction—eliminating more than half his position in a single filing—paired with his demonstrated prior timing accuracy and current negative price momentum, deserves investor attention as a data point in assessing near-term stock direction.

IDXX EVP Fennell sold 9,986 shares (-55.0% of holdings) for $4.6M at $462.53; consistent with prior pattern of well-timed sells.

Fennell George, Executive Vice President of IDEXX LABORATORIES INC /DE, executed a substantial open-market sale on 2025-02-10, reducing his holdings from 18,162 shares to 8,176 shares—a 55.0% reduction. The transaction occurred at $462.53 per share, valuing the 9,986-share sale at $4,618,861.53 ($4.6M). His track record across all tickers shows 5 prior sells with an average 90-day return of -15.1% and a 90-day well-timed rate of 100.00%, indicating consistent exit discipline. At the same-ticker level, all 5 prior sells at IDXX were well-timed at the 90-day mark (ranging from -14.9% to -15.4% post-sale). The current stock price of $463.74 sits 19.6% below the 52-week high of $576.87, suggesting the sale occurred well above current depressed levels. This sale pattern—large, deliberate reduction coupled with a demonstrated cross-ticker and same-ticker history of well-timed exits—warrants investor attention as a potential negative signal, though IDXX fundamentals remain solid with $975.5M quarterly revenue, $232.8M net income, and 8.7% annual revenue growth.